Monocarboxylate Transporter 1 (MCT1) is an independent prognostic biomarker in endometrial cancer

BACKGROUND: Endometrial cancer (EC) is a major health concern due to its rising incidence. Whilst early stage disease is generally cured by surgery, advanced EC has a poor prognosis with limited treatment options. Altered energy metabolism is a hallmark of malignancy. Cancer cells drive tumour growt...

Descripción completa

Detalles Bibliográficos
Autores principales: Latif, Ayşe, Chadwick, Amy L., Kitson, Sarah J., Gregson, Hannah J., Sivalingam, Vanitha N., Bolton, James, McVey, Rhona J., Roberts, Stephen A., Marshall, Kay M., Williams, Kaye J., Stratford, Ian J., Crosbie, Emma J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745908/
https://www.ncbi.nlm.nih.gov/pubmed/29299023
http://dx.doi.org/10.1186/s12907-017-0067-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745908/
https://www.ncbi.nlm.nih.gov/pubmed/29299023
http://dx.doi.org/10.1186/s12907-017-0067-7

Ejemplares similares